Target
Cyclin-dependent kinase 9
Ligand
BDBM180838
Substrate
n/a
Meas. Tech.
CDK9/CycT1 Kinase Assay
pH
8±n/a
Temperature
295.15±n/a K
IC50
4±n/a nM
Comments
extracted
Citation
 Lücking, UKosemund, DScholz, ALienau, PSiemeister, GBömer, UBohlmann, R Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group US Patent  US9133171 Publication Date 9/15/2015 
Target
Name:
Cyclin-dependent kinase 9
Synonyms:
C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:
Enzyme Subunit
Mol. Mass.:
42789.13
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF
  
Inhibitor
Name:
BDBM180838
Synonyms:
US9133171, 43 | US9133171, 44 | US9133171, 45
Type:
Small organic molecule
Emp. Form.:
C20H19F3N4O2S
Mol. Mass.:
436.451
SMILES:
CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(n2)-c2ccc(F)cc2OC)c1
Structure:
Search PDB for entries with ligand similarity: